About Ribo
Science
Pipeline
Collaboration
Investors
Careers
About Ribo
International R&D Center
Scientific Advisory Board
Our Culture
News
About Oligonucleotide Therapeutics
Technological Innovations
Intellectual Property
Pipeline
Products
Clinical Trials
BD and Collaboration
Overview
Our Culture
Career Development
Recruitment
CN
B3-pcbanner.jpg B3-phbanner.jpg
News
About RiboNews
Ribo Closed $40M Series E1 Financing to support global development of the diversified pipelines and continuous advancement of siRNA technologies.
Jul 29,2022
Last : Ribo Announces China CDE Approval of Clinical Trial Application of RBD7022 First-In-Human Clinical Trial in China for Treatment of Hyperlipidemia.
Next : Ribocure Pharmaceuticals Moves Into GoCo Clinic - Putting North Europe in the Spotlight Within Oligonucleotide Therapeutics